Posts By / cmcgowan

IMIV MRI Pump Priming Research Scheme – Round 2

Following on from last year’s successful IMIV MRI Pump-Priming Research Scheme, we are pleased to launch a second round of the scheme to support innovative MRI research projects.


The aim of the scheme is to support projects that will lead to competitive external funding applications for MR imaging studies.  Applications will therefore be required to demonstrate a clear plan for progressing preliminary studies to grant applications and larger studies.


  • All projects must have a Bournemouth University researcher as lead or co-lead applicant (see application form).


  • In Round 2, there will be several application windows rather than a single deadline. Up to 200 hours of scanning time will be awarded in total.


  • There is no limit on the number of scanning hours that can be applied for, but projects applying for an award of more than 20 hours may be subject to external peer review. Awards will not cover any additional expenses related to scanning, or other aspects of the project.


  • Projects must be deliverable within 12 months, including ethical approvals. Projects with ethical approvals already in place will be prioritised.


The first window for applications is now open, and closes on Friday 7th January 2022.  There will be further application windows during the year.

To receive the application form, please email

Institute of Medical Imaging and Visualisation to be part of study to test new Alzheimer’s diagnostic tool

BU’s Institute of Medical Imaging and Visualisation (IMIV) will be part of a project awarded funding by the National Institute for Health Research (NIHR) to test a new Alzheimer’s diagnostic tool in the NHS.

The three-year multi-centre study, led by Oxford Brain Diagnostics (OBD), aims to assess the use of Cortical Disarray Measurement (CDM®) as a tool to identify and predict disease progression amongst patients presenting with mild cognitive impairment due to Alzheimer’s disease.

As part of the project, a total of 300 MRI scans from NHS patients in the early stages of the disease will be examined using CDM to distinguish patient cohorts and measure changes in brain structure over time.

This will enable the project team to assess how improved diagnosis will impact on current treatment pathways and patient outcomes, and to assess future economic impact across primary, secondary, and social care.

IMIV will be one of the centres carrying out imaging for this study using its state-of-the-art Siemens Lumina 3T MRI scanner. IMIV MRI Operations Manager John Totman said: “Our Siemens scanner has the capacity and capabilities to perform complex neuroimaging research studies, and we look forward to working with OBD in delivering this project.”

The project also involves the University of Oxford Health Economics Research Centre, University Hospital Southampton NHS Foundation Trust, NIHR Community Healthcare MedTech and IVD Cooperative, Cardiff and the Vale University Health Board, the University of Southampton, and Cardiff University.

It has been awarded funding of £1.4m from the NIHR Invention for Innovation (i4i) programme.

Dr Jamie Franklin, Head of the Institute of Imaging and Visualisation, said, “We are excited to be using Bournemouth University’s fantastic imaging facilities to contribute to this innovative and collaborative project.”